2-166281777-C-T
Variant summary
Our verdict is Likely benign. The variant received -2 ACMG points: 0P and 2B. BP4_Moderate
The NM_001365536.1(SCN9A):c.2006G>A(p.Arg669His) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000701 in 1,612,672 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. R669C) has been classified as Likely benign.
Frequency
Consequence
NM_001365536.1 missense
Scores
Clinical Significance
Conservation
Publications
Genome browser will be placed here
ACMG classification
Our verdict: Likely_benign. The variant received -2 ACMG points.
Variant Effect in Transcripts
ACMG analysis was done for transcript: NM_001365536.1. You can select a different transcript below to see updated ACMG assignments.
RefSeq Transcripts
| Selected | Gene | Transcript | Tags | HGVSc | HGVSp | Effect | Exon Rank | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|---|
| SCN9A | NM_001365536.1 | MANE Select | c.2006G>A | p.Arg669His | missense | Exon 13 of 27 | NP_001352465.1 | ||
| SCN9A | NM_002977.4 | c.1973G>A | p.Arg658His | missense | Exon 13 of 27 | NP_002968.2 | |||
| SCN1A-AS1 | NR_110260.1 | n.1029+4530C>T | intron | N/A |
Ensembl Transcripts
| Selected | Gene | Transcript | Tags | HGVSc | HGVSp | Effect | Exon Rank | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|---|
| SCN9A | ENST00000642356.2 | MANE Select | c.2006G>A | p.Arg669His | missense | Exon 13 of 27 | ENSP00000495601.1 | ||
| SCN9A | ENST00000303354.11 | TSL:5 | c.2006G>A | p.Arg669His | missense | Exon 13 of 27 | ENSP00000304748.7 | ||
| SCN9A | ENST00000409672.5 | TSL:5 | c.1973G>A | p.Arg658His | missense | Exon 13 of 27 | ENSP00000386306.1 |
Frequencies
GnomAD3 genomes AF: 0.0000592 AC: 9AN: 151962Hom.: 0 Cov.: 32 show subpopulations
GnomAD2 exomes AF: 0.000105 AC: 26AN: 248158 AF XY: 0.0000817 show subpopulations
GnomAD4 exome AF: 0.0000712 AC: 104AN: 1460592Hom.: 0 Cov.: 30 AF XY: 0.0000537 AC XY: 39AN XY: 726568 show subpopulations
Age Distribution
GnomAD4 genome AF: 0.0000592 AC: 9AN: 152080Hom.: 0 Cov.: 32 AF XY: 0.0000538 AC XY: 4AN XY: 74330 show subpopulations
Age Distribution
ClinVar
Submissions by phenotype
not provided Uncertain:4
In silico analysis, which includes protein predictors and evolutionary conservation, supports a deleterious effect; Has not been previously published as pathogenic or benign to our knowledge
Available data are insufficient to determine the clinical significance of the variant at this time. The frequency of this variant in the general population is uninformative in assessment of its pathogenicity. (http://gnomad.broadinstitute.org) Polyphen and MutationTaster predict this amino acid change may be benign.
Inborn genetic diseases Uncertain:1
The c.1973G>A (p.R658H) alteration is located in exon 13 (coding exon 12) of the SCN9A gene. This alteration results from a G to A substitution at nucleotide position 1973, causing the arginine (R) at amino acid position 658 to be replaced by a histidine (H). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear.
Primary erythromelalgia;C0751122:Severe myoclonic epilepsy in infancy;C1833661:Paroxysmal extreme pain disorder;C1855739:Channelopathy-associated congenital insensitivity to pain, autosomal recessive;C2751778:Generalized epilepsy with febrile seizures plus, type 7;C2752089:Neuropathy, hereditary sensory and autonomic, type 2A Uncertain:1
Generalized epilepsy with febrile seizures plus, type 7;C2752089:Neuropathy, hereditary sensory and autonomic, type 2A Benign:1
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at